← All patterns

Adrenal mass

AbdomenCT / MRI

An incidental or symptomatic adrenal lesion. Unenhanced attenuation, chemical-shift signal loss and enhancement washout separate the common benign adenoma from other entities.

Differential

Adenoma (lipid-rich)

common
  • Unenhanced attenuation ≤10 HU
  • Signal drop on opposed-phase chemical-shift MRI
  • Absolute washout >60% / relative >40%

Metastasis

common
  • Unenhanced >10 HU with low washout
  • Known primary (lung, breast, melanoma), often bilateral
  • Interval growth

Myelolipoma

less-common
  • Macroscopic fat (negative HU) with myeloid tissue
  • India-ink chemical-shift artefact at fat interfaces

Phaeochromocytoma

less-common
  • Avid enhancement, markedly T2-bright ("light bulb")
  • Cystic/haemorrhagic change; low washout
  • Catecholamine excess (paroxysmal hypertension)

Adrenal haemorrhage

rare
  • High attenuation, non-enhancing, decreases over time
  • Trauma, anticoagulation, sepsis

Adrenocortical carcinoma

rare
  • Large (>4–6 cm), heterogeneous with necrosis/calcification
  • Venous invasion; hormone hypersecretion

Key discriminators

  • Unenhanced attenuation (≤10 HU = benign adenoma)
  • Chemical-shift signal drop (intracellular lipid)
  • Absolute/relative enhancement washout
  • Macroscopic fat (myelolipoma)
  • Size and heterogeneity (carcinoma)

Work-up / next steps

  1. 1.Dedicated adrenal CT protocol (unenhanced + 60 s + 15 min washout)
  2. 2.Chemical-shift MRI for indeterminate lipid-poor lesions
  3. 3.Biochemical screen (metanephrines, cortisol, aldosterone) as indicated
  4. 4.FDG-PET or biopsy for suspected metastasis when it alters management

References

  • Boland GW et al. Adrenal imaging. Radiology.
  • Radiopaedia: Adrenal mass.

Educational clinical decision support only. This differential does not make a diagnosis, is not a medical device, and must never substitute for interpretation by a qualified radiologist correlated with the full clinical picture and prior imaging.